MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy

Off Science and Research

A study has identified a possible second-line treatment for melanoma patients.
Read Original Article: MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy »

About The Author